DHA-Paclitaxel in Treating Patients With Metastatic Pancreatic Cancer

PHASE2UnknownINTERVENTIONAL
Timeline

Start Date

June 30, 2001

Conditions
Pancreatic Cancer
Interventions
DRUG

DHA-paclitaxel

Trial Locations (9)

10016

NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York

98101

Virginia Mason Medical Center, Seattle

21231-2410

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

19107-5541

Kimmel Cancer Center of Thomas Jefferson University - Philadelphia, Philadelphia

D-45136

Kliniken Essen - Mitte, Essen

D-60488

Krankenhaus Nordwest, Frankfurt

3008 EA

Erasmus Medical Center, Rotterdam

WV10 0QP

New Cross Hospital, Wolverhampton

G11 6NT

Beatson Oncology Centre, Glasgow

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Theradex

INDUSTRY

NCT00024375 - DHA-Paclitaxel in Treating Patients With Metastatic Pancreatic Cancer | Biotech Hunter | Biotech Hunter